The role of thrombospondin-1 in cardiovascular health and pathology

Smriti Murali Krishna1, Jonathan Golledge

  • 1The Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, School of Medicine and Dentistry, James Cook University, Australia.

Insights

Thrombospondin-1 (TSP-1) plays a complex role in cardiovascular diseases (CVDs) by influencing vascular cell function and tissue remodeling. Understanding TSP-1's varied effects may lead to new therapeutic strategies for CVD.

Area of Science:

  • Cardiovascular Biology
  • Extracellular Matrix Research
  • Immunology

Background:

  • Cardiovascular diseases (CVDs) are a major global health concern, driving research into improved therapeutic strategies.
  • Thrombospondin-1 (TSP-1), an extracellular matrix protein, significantly impacts vascular cell behavior and tissue remodeling.
  • Existing therapies for CVDs are limited, necessitating a deeper understanding of disease pathogenesis.

Purpose of the Study:

  • To elucidate the multifaceted role of Thrombospondin-1 (TSP-1) in the pathogenesis of cardiovascular diseases (CVDs).
  • To explore how TSP-1 influences vascular cell function, tissue remodeling, and inflammatory responses relevant to CVD.
  • To investigate the potential of TSP-1-derived peptides as novel therapeutic agents for CVD.

Main Methods:

  • Review and synthesis of in vitro and animal studies investigating TSP-1's effects on vascular cells (smooth muscle cells, endothelial cells, fibroblasts).
  • Analysis of TSP-1 receptor interactions (CD36, proteoglycans, integrins) and downstream signaling pathways.
  • Examination of TSP-1's influence on matrix production, tissue remodeling, angiogenesis, and T regulatory cell generation.

Main Results:

  • Conflicting findings exist regarding TSP-1's effects, dependent on experimental context and cellular environment.
  • TSP-1 modulates matrix production, tissue remodeling, and the inflammatory response via T regulatory cells.
  • Different TSP-1 domains activate distinct signaling pathways, leading to varied cellular phenotypes and tissue-specific effects.

Conclusions:

  • The precise mechanism of TSP-1 in CVD is complex due to context-dependent signaling and receptor interactions.
  • Further understanding of TSP-1's role in various CVDs offers potential for new therapeutic interventions.
  • TSP-1-derived peptides are under evaluation and may represent a promising avenue for CVD treatment.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...